Demonstrating Value for Biosimilars: A Conceptual Framework

BACKGROUND: The value proposition for biosimilars can be characterized as a concept that moves beyond the argument of cost reduction relative to the innovator biologic drug and into a framework that incorporates the diverse needs of key healthcare stakeholders during the transition from clinical dev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am Health Drug Benefits
Hauptverfasser: Rompas, Sotiris, Goss, Thomas, Amanuel, Sally, Coutinho, Victoria, Lai, Zhihong, Antonini, Paola, Murphy, Michael F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Engage Healthcare Communications, LLC 2015
Schlagworte:
Business
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4467014/
https://ncbi.nlm.nih.gov/pubmed/26085901
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge